NovoCure Limited Earnings

NovoCure Limited’s revenue jumped 8.11% since last year same period to $174.35Mn in the Q4 2025. On a quarterly growth basis, NovoCure Limited has generated 4.27% jump in its revenue since last 3-months.

NovoCure Limited’s net profit jumped 62.84% since last year same period to $-24.5Mn in the Q4 2025. On a quarterly growth basis, NovoCure Limited has generated 34.27% jump in its net profits since last 3-months.

NovoCure Limited’s net profit margin jumped 65.63% since last year same period to -14.05% in the Q4 2025. On a quarterly growth basis, NovoCure Limited has generated 36.96% jump in its net profit margins since last 3-months.

NovoCure Limited’s earning per share (EPS) estimates for the current quarter stand at -0.39 - a 5.01% jump from last quarter’s estimates.

NovoCure Limited’s earning per share (EPS) estimates for the current year stand at -0.39.

NovoCure Limited’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the NovoCure Limited has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.